Agenda
  • OCT 09, 2019 06:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Multilevel Interventions in Cancer Prevention and Control: A Community-Based Translational Research Framework to Address Prostate Cancer Disparities
  • OCT 09, 2019 07:30 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Keynote Presentation: Pairing protein profiling with drug screens uncovers an effective therapy against high risk leukemia
    Speaker: Ernesto Diaz-Flores, PhD
  • OCT 09, 2019 09:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Start at the End: A Strategy for Developing and Delivering Advanced Diagnostic Tests to improve Prostate Cancer Patient Outcomes
    Speaker: Stephen Pennington
    Sponsored By: Agilent
  • OCT 09, 2019 10:30 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    A practical guide for multiplexed ion beam imaging to reveal tumor immunobiology
    Speaker: Selena Ferrian
    Sponsored By: IONpath
  • OCT 09, 2019 12:00 PM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Next Steps in Personalized Medicine- Using Genomics and Imaging For Treatment Selection in Early Stage Prostate Cancer
  • OCT 10, 2019 06:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Highly-efficient and -specific genome editing with Cas9 nickase ribonucleoproteins in Primary T-cells
    Speaker: Jacob Lamberth
    Sponsored By: MilliporeSigma
  • OCT 10, 2019 10:30 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Transcriptional Profiling of the Pediatric Tumor Microenvironment
    Speaker: Troy McEachron, PhD
    Sponsored By: NanoString Technologies
  • Novel Cancer Therapeutics and Cancer Prevention
  • OCT 09, 2019 06:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Multilevel Interventions in Cancer Prevention and Control: A Community-Based Translational Research Framework to Address Prostate Cancer Disparities
  • OCT 09, 2019 09:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Start at the End: A Strategy for Developing and Delivering Advanced Diagnostic Tests to improve Prostate Cancer Patient Outcomes
    Speaker: Stephen Pennington
    Sponsored By: Agilent
  • OCT 09, 2019 10:30 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    A practical guide for multiplexed ion beam imaging to reveal tumor immunobiology
    Speaker: Selena Ferrian
    Sponsored By: IONpath
  • OCT 10, 2019 06:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Highly-efficient and -specific genome editing with Cas9 nickase ribonucleoproteins in Primary T-cells
    Speaker: Jacob Lamberth
    Sponsored By: MilliporeSigma
  • Tumor Drug Resistance and Tumor Evolution
  • OCT 09, 2019 07:30 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Keynote Presentation: Pairing protein profiling with drug screens uncovers an effective therapy against high risk leukemia
    Speaker: Ernesto Diaz-Flores, PhD
  • Molecular Guidance Versus Standard of Care
  • OCT 09, 2019 12:00 PM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Next Steps in Personalized Medicine- Using Genomics and Imaging For Treatment Selection in Early Stage Prostate Cancer
  • OCT 10, 2019 10:30 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Transcriptional Profiling of the Pediatric Tumor Microenvironment
    Speaker: Troy McEachron, PhD
    Sponsored By: NanoString Technologies
OCT 9 - 10 2019 Opens: 6:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar

Cancer Research & Oncology 2019

LabRoots and the Cancer Research and Oncology Planning Committee are pleased to announce the 7th Annual Cancer Research and Oncology Virtual Event! This 2-day event will take place on October 9-10, 2019 and will focus on advancements in prevention, diagnosis and treatment of different cancer types.

Cancer research has made major advancements in diagnosis, treatments, and the basic understanding of the disease itself. Each year we see progress in immunotherapy, treatments involving nanotechnology, advances in targeted and personalized therapeutics and drug development, and a decrease in mortality rates due to a strong focus on learning more about the origination of the disease.

The tracks for this year's event include: 

  • Tumor Drug Resistance and Tumor Evolution
  • Radiation Resistance
  • Novel Cancer Therapeutics and Cancer Prevention
  • Molecular Guidance Versus Standard of Care
     

The free, two-day online event will bring research professionals, scientists, and clinicians from around the world to learn and discuss recent advances in cancer research. As with all LabRoots event, the Cancer Research and Oncology Event encourages a worldwide collaboration and connections between colleagues and field experts.

Our virtual conference allows you to participate in a global setting with no travel or cost to you. The event will remain open 6 months from the date of the live event.  The webinars will be available for unlimited on-demand viewing.  This virtual conference also offers increased reach for the global cancer community with a high degree of interaction through live-streaming video and chat sessions.

Like the 2018 conference, this event will be produced on our robust virtual platform, allowing you to watch, learn and connect seamlessly across all desktop or mobile devices. Equipped with gamification and point system, you can now move around the entire event, earning points for a chance to win one of LabRoots most popular shirts.



 

Call for Posters — Virtual poster sessions offer the opportunity to present data to a global audience via a PDF poster and video summary, and discuss results with interested colleagues through email. Plan now to have your poster included in the 2019 Cancer Research and Oncology Virtual Event. Submission is free. Submit your abstract here.

Continuing Education
LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this event, you can earn 1 Continuing Education credit per presentation for a maximum of 32 credits.

Use #LRcancer to follow the conversation!


Speakers

Show Resources
You May Also Like
MAR 27, 2019 06:00 AM PDT
C.E. CREDITS
MAR 27, 2019 06:00 AM PDT
For the second year in a row, LabRoots is pleased to announce the 2019 Cannabis Sciences Virtual Event. LabRoots will host the 2nd annual event March 27-28, 2019.The Cannabis Sciences plannin...
APR 10, 2019 06:00 AM PDT
C.E. CREDITS
APR 10, 2019 06:00 AM PDT
LabRoots and the Molecular Diagnostics planning committee are excited to announce they will be hosting the 4th Annual Molecular Diagnostics Virtual Conference April 10-11, 2019. This premiere...
JUN 05, 2019 06:00 AM PDT
C.E. CREDITS
JUN 05, 2019 06:00 AM PDT
Re-define the workflows and possibilities of cell biology by joining our virtual event!This event offers an overview of how live-cell analysis enables real-time analysis for the full work...
NOV 14, 2019 06:00 AM PST
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
NOV 14, 2019 06:00 AM PST
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
Ten years ago LabRoots launched a new system of learning for a global scientific audience. Now, the 2019 Clinical Diagnostics and Research Virtual Event will again bring together clinicians,...
MAY 08, 2019 06:00 AM PDT
C.E. CREDITS
MAY 08, 2019 06:00 AM PDT
LabRoots and the Genetics and Genomics planning committee are excited to announce they will be hosting the 7th Annual Genetics and Genomics Virtual Event May 8-9, 2019. This distinguished, on...
APR 25, 2019 06:00 AM PDT
C.E. CREDITS
APR 25, 2019 06:00 AM PDT
In an effort to provide a platform to discuss leading scientific research on a range of topics, LabRoots has added another virtual event to the line up of conferences for 2019 – Infecti...
Speakers

  • Ernesto Diaz-Flores, PhD
    Assistant Adjunct Professor in the Department of Pediatrics/Hematology at UCSF
    Biography
      Ernesto Diaz-Flores, PhD, is an Assistant Adjunct Professor in the Department of Pediatrics/Hematology at UCSF. He is an experienced biochemist with a focus on identifying novel therapeutics for high-risk childhood leukemia. Dr. Diaz-Flores obtained his BsC in Biochemistry at the Universidad Complutense (Madrid) and his PhD in molecular biology for his studies of lymphocyte activation at the Universidad Autonoma (Madrid). He came to UCSF for his postdoctoral studies first under the supervision of Dr Kevin Shannon, studying murine models of Kras leukemia and then pursuing a second postdoctoral fellowship in Dr. Mignon Loh's laboratory. Dr Diaz-Flores specializes in identifying novel therapies for children with hypodiploid leukemia. His work combines the study of dysregulated signaling networks, transcriptomics analysis and drug assays. He further validates drugs with therapeutic potential running in vivo preclinical trials using patient derived xenografted models. His latest work has informed a clinical trial for patients with high-risk leukemia
    • Sven Bocklandt, PhD
      Director, Scientific Affairs, Bionano Genomics
      Biography
        Dr. Sven Bocklandt is a human geneticist with a background in gene discovery. He received his PhD from the University of Antwerp, Belgium, based on research on the genetic components of brain sexual differentiation performed at the National Cancer Institute, and at the University of California Los Angeles. As Director of Scientific Affairs at Bionano Genomics, he focuses on the scientific discoveries made on the Bionano platform and is leading clinical validation studies on Bionano's performance in genetic disease and cancer diagnostics.
      • Selena Ferrian
        Sr.Staff Scientist/LSRP3, Stanford University
        Biography
          Prior to Stanford Selena worked as a Research Scientist within the Immunotherapy Platform, led by Nobel laureate Professor James Allison at MD Anderson Cancer Center, where she analyzed and interpreted data for immunotherapy clinical trials and implemented an imaging technology to study the immune landscape in metastatic renal cell carcinoma. As a Sr. Scientist at Stanford University, Selena is interested in investigating the role of glioma infiltrating macrophages in disease pathogenesis. More specifically, she wants to understand how cell-cell communication affects macrophage cell types and states in Glioblastoma in order to accelerate future immunotherapy strategies. Concomitantly Selena is overseeing and supporting Dr. Angelo's research collaborations derived from the implementation of the MIBI technology in diseased tissue.
        • Troy McEachron, PhD
          Assistant Professor of Research, Translational Genomics, University of Southern California, Keck School of Medicine
          Biography
            Dr. McEachron received his PhD in Cellular and Molecular Pathology from the University of North Carolina at Chapel Hill and completed postdoctoral training at both the St. Jude Children's Research Hospital and at the Translational Genomics Research Institute. Dr. McEachron is currently an Assistant Professor in the Department of Translational Genomics and the Department of Pediatrics at the Keck School of Medicine of the University of Southern California. Dr. McEachron's research employs integrated multi-parametric approaches to reveal how the genomic complexity of pediatric osteosarcoma influences the tumor microenvironment and, in response, how the microenvironment supports the growth of such genomically unstable tumors. Dr. McEachron's research interests reflect his diverse training history which includes the molecular dissection of autocrine and paracrine signaling mechanisms between tumor and host using in vitro and in vivo models, the characterization of genetically engineered mouse models of pediatric brain tumors, and the interpretation and functional validation next generation sequencing data from recurrent/refractory pediatric cancer patients for clinical decision making.
          • Jacob Lamberth
            R&D Scientist, Genome and Epigenome Editing: MilliporeSigma
            Biography
              Jacob has been working on developing and testing Cas9 products in the Genome Engineering team at MilliporeSigma since joining the company in 2015. He has led the R&D testing and has evaluated dozens of CRISPR systems, on top of helping Quality Control testing of the CRISPR products that MilliporeSigma currently sells. Recently he has focused on the development of multiple Cas9 Ribonucleoproteins and their potential therapeutic applications. Before joining MilliporeSigma, Jacob worked as a lab technician and research assistant in the Brickner Lab at Northwestern University
            • Stephen Pennington
              Professor of Proteomics, Founder, CEO and CSO Atturos Ltd. C/O UCD Conway Institute University College Dublin
              Biography
                Steve is Professor of Proteomics at University College Dublin, Ireland. A chemist (Imperial College, London) and PhD biochemist (University of Cambridge) by training. Through engagement in a series of collaborations and international consortia, his current biomedical proteomics research is directed to the discovery and development of protein biomarkers. On-going projects are focussed on the mass spectrometry based measurement and evaluation of protein biomarkers in oncology and inflammatory disease to progress them to clinical utility. Steve's team are also investigating the mechanisms of disease progression focussing on prostate cancer and psoriatic arthritis. Steve is highly energetic and enthusiastic with an innovative, open and inclusive approach to his work. He has given over 200 invited presentations at international events, published over 80 scientific papers, edited and contributed to several books including editing one of the first books on Proteomics that was translated into Chinese and Japanese. Steve has held roles as a committee member in the British Society for Proteome Research (currently vice-President, and the European Proteomics Association. He is the lead organiser of the forthcoming annual world congress of the Human Proteome Organisation (HUPO) that will be held in the national Convention Centre in Dublin from 17-21st September 2017 (www.hupo2017.ie). Recently, Steve founded the UCD spinout company 'Atturos' (Dec 2016) to support the delivery of OCProDx to clinical use. OCProDx is a prostate cancer blood-based biomarker test that has the capability to distinguish patients with organ-confined and non-organ confined disease. The test will help inform men diagnosed with prostate cancer whether they should go on or stay on 'active surveillance' The Atturos team has the expertise and experience to deliver this and other multiplexed protein biomarker tests to market.
              • Brian Rivers, PhD, MPH
                Director of the Cancer Health Equity Institute Morehouse School of Medicine (MSM)
                Biography
                  Dr. Rivers is the Director of the Cancer Health Equity Institute at Morehouse School of Medicine (MSM). Dr. Rivers is nationally and internationally recognized as a leader in cancer disparities research and currently serves as a member of the National Institutes of Health (NIH) National Advisory Council on Minority Health and Health Disparities (NACMHD). Dr. Rivers is an active member in the American Association for Cancer Research (AACR) community and regularly serves on the faculty for the Scientist to Survivor program. More recently, Dr. Rivers was elected to serve as Chairperson for the Minorities in Cancer Research Council of the AACR. Dr. Rivers is a behavioral scientist with a broad background in implementation science and public health, with specific training and expertise in health behavior research methodologies for addressing health disparities, such as the lay health model and Community-based Participatory Research framework. Dr. Rivers' specific program of research is focused on addressing prostate cancer disparities among African Americans and exploring the role of novel communication interventions, such as mobile health technology. Currently, Dr. Rivers is leading several large randomized controlled trials, funded by NIH and NIMHD R01, to evaluate and characterize app usage and acceptability for education and care coordination among African American men diagnosed with prostate cancer. Dr. Rivers is Multiple-Principal Investigator for the NIH NCI funded U54 Cancer Research Partnership between MSM, Tuskegee University, and the University of Alabama-Birmingham Comprehensive Cancer Center (UAB CCC). Dr. Rivers also directs the Integrating Special Populations Program of the NIH NCATS funded Georgia Clinical and Translational Science Alliance.
                • Anson Tharayanil
                  Medical Science Liaison (Urology), Genomic Health, Inc.
                  Biography
                    Anson Tharayanil graduated from University of California, Davis with a degree in Biological Sciences. With over a decade of experience in the biotechnology space, he has helped bring several multigene signature tests for breast, colon, and prostate cancer into clinical use. His passion is in educating both physicians and patients on the use and value of genomic tests to optimize cancer care.
                  Sponsored By

                  For information on becoming a sponsor or exhibitor, please click here.


                  C.E. Credits

                  The speakers below have been approved for CME, CE, or CEU credits. To redeem your credits, locate the presentation you watched and click on the CME/CE/CEU buttons for further direction. For more general information regarding continuing education, the processes to receive credits, and the accreditation bodies, Click here


                  Posters

                  POSTER SUBMISSION GUIDELINES

                  Virtual poster sessions offer the opportunity to present data to a global audience via a PDF poster and video summary, and discuss results with interested colleagues through email. Posters should be submitted as a PowerPoint file. Presentations should incorporate illustrative materials such as tables, graphs, photographs, and large-print text. This content is not peer-reviewed. Submission is free.


                  SUBMIT YOUR ABSTRACT

                  Enter the following information to this Submission Form:

                  • Poster Title
                  • Your Name
                  • Your Institution
                  • Your Email
                  • Abstract describing the poster


                  All submitted abstracts will be reviewed and decisions regarding acceptance will be made as abstracts are received. You will be notified within one week of receipt about acceptance. Further details and registration materials will be provided at that time. You do not have to be present in order to have a poster displayed. Only those abstracts approved by LabRoots may display posters at this event.

                  If accepted, you will also have the opportunity to record a 3-5 minute summary video for each poster. LabRoots will work with each individual to create these videos. Video links and email contact information will be included on each poster displayed.

                  Questions? Email Posters@LabRoots.com

                  LabRoots Policy

                  Committee

                  To download the Program Committee brochure here.


                  • David Albala

                    Dr. David M. Albala graduated with a geology degree from Lafayette College in Easton, Pennsylvania. He completed his medical school training at Michigan State University and went on to complete his surgical residency at the Dartmouth-Hitchcock Medical Center. Following this, Dr ...

                    See more See less
                  • Antonio Baines

                    Dr. Antonio T. Baines is an Associate Professor in the Department of Biology at North Carolina Central University (NCCU) and an adjunct professor in the Department of Pharmacology in the School of Medicine at the University of North Carolina (UNC) Chapel Hill. He earned a ...

                    See more See less
                  • Rajan Gupta

                    Dr. Rajan T. Gupta, MD, is an Assistant Professor of Radiology in the Division of Abdominal Imaging at Duke University Medical Center, as well as the Director of the Abdominal Imaging Fellowship Program and a Faculty physician in the Duke Cancer Institute. Since 2009, he has been ...

                    See more See less
                  • Keith Knutson

                    Keith L. Knutson, Ph.D., is a consultant in the Department of Immunology, Mayo Clinic in Florida, where he also serves as director of the Discovery and Translation Lab's Cancer Research Program. Dr. Knutson joined the staff of Mayo Clinic in 2005 and holds the academic rank of ...

                    See more See less
                  • Jonas Korlach

                    Jonas Korlach was appointed Chief Scientific Officer of Pacific Biosciences in July 2012. He was previously a Scientific Fellow, supporting commercial development of the PacBio RS II system and performing research aimed at developing new applications for SMRT technologies. He ...

                    See more See less
                  • Martin Latterich

                    The discovery of proteinaceous disease biomarkers and their clinical validation is critically important for the enablement of molecular diagnostics and ultimately, precision medicine. In spite of the importance of biomarkers, research done in the last two decades has yielded ...

                    See more See less
                  • Thomas Polascik

                    Thomas J. Polascik, M.D. is Professor in the Duke Cancer Institute, the Department of Surgery at the Duke University Medical Center, Durham, NC. Dr. Polascik trained at the Brady Urological Institute, the Johns Hopkins Hospital in Baltimore Maryland. After finishing his residency ...

                    See more See less
                  • Khyati Shah

                    Khyati Shah received her Ph.D. in Molecular Pharmacology from the University of the Pacific, Stockton, California. Her graduate research was completed in the lab of Jesika Faridi, Ph.D. Her work focused on the investigation of the mechanism of Akt induced tamoxifen resistance in ...

                    See more See less
                  Help

                  General LabRoots Questions

                  For bugs, spam, technical support or questions please call +1-714-463-4673 or email support@labroots.com  
                  Contact us

                  Virtual Events and Webinars

                  Supported Configurations

                  • Operating System Internet Explorer Firefox Chrome Safari
                    Vista IE8+ FF10+ Chrome15+
                    Windows 7 IE8+ FF10+ Chrome15+
                    Windows 8 IE10 FF10+ Chrome15+
                    Mac OS X   FF10+ Chrome15+ Safari5.1+
                  • Cookie settings: session cookies enabled
                  • Browser configuration must have JavaScript enabled
                  • Adobe Flash player 10.2 or later

                  To watch our webinars and virtual events a modern browser such as Chrome, Firefox, Safari, or an updated version of Internet Explorer is required.

                  Internet Connection

                  • A minimum of 100Kbps is recommended for audio-only events
                  • A minimum of 300Kbps is recommended for speaker on-video events

                  Computer Equipment

                  • Screen Resolution: Minimum 1024x768
                  • Video Card: 65,000 colors minimum
                  • Sound card and speakers (or headphones) for hearing webcast in full format
                  • Audio Card: 16-bit minimum
                  • RAM: 512MB of free RAM

                  Firewall Protocol

                  • HTTP on port 80 or HTTPS on port 443
                  • Adobe RTMP on port 1935, 80, or 443 with automatic fall-back to RTMPT (RTMP tunneling) on ports 1935, 80 or 443
                  • RTMPE (RTMP encrypted) on ports 1935, 80 or 443

                  Work-At-Home Attendees

                  • If a corporate VPN is used, confirm that your network traffic is not directed over the company VPN. If it is, please turn off the VPN while attending the virtual event.

                  For A Seamless Experience

                  When using a mobile device, FREE Mobile Apps are available:

                  - For viewing Webinars:

                  - For viewing Virtual Events

                  Attendee Guide

                  • To learn more about how the virtual event works for attendees, download the Attendee Guide (PDF).

                  Virtual Event and Webinar Support:

                  Continuing Education (CME/CE) Support

                  Loading Comments...
                  Show Resources
                  Event Countdown
                  • 0 Days
                  • 0 Hours
                  • 0 Minutes
                  • 0 Seconds